Both familial and sporadic mutations in the coding and cis-regulatory regions of GATA2 are found and are the underlying cause in 15% of advanced and 7% of all pediatric MDS cases (Wlodarski et al., 2016). The gene discussed is GATA2; the disease is myelodysplastic syndrome.